Chemed Co. (NYSE:CHE) Holdings Trimmed by NBC Securities Inc.

NBC Securities Inc. trimmed its stake in shares of Chemed Co. (NYSE:CHE) by 22.7% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 355 shares of the company’s stock after selling 104 shares during the period. NBC Securities Inc.’s holdings in Chemed were worth $227,000 as of its most recent SEC filing.

Several other hedge funds have also recently bought and sold shares of the business. CWM LLC lifted its holdings in shares of Chemed by 8.4% during the 1st quarter. CWM LLC now owns 335 shares of the company’s stock valued at $215,000 after buying an additional 26 shares during the last quarter. Kapitalo Investimentos Ltda bought a new stake in shares of Chemed during the fourth quarter valued at approximately $499,000. Quadrature Capital Ltd bought a new stake in shares of Chemed during the fourth quarter valued at approximately $13,476,000. EP Wealth Advisors LLC increased its position in shares of Chemed by 3.1% during the fourth quarter. EP Wealth Advisors LLC now owns 1,887 shares of the company’s stock valued at $1,103,000 after purchasing an additional 57 shares during the period. Finally, Virtu Financial LLC bought a new stake in shares of Chemed during the fourth quarter valued at approximately $612,000. 95.85% of the stock is owned by hedge funds and other institutional investors.

Chemed Price Performance

CHE stock opened at $542.47 on Friday. The business has a 50-day moving average of $563.69 and a 200-day moving average of $590.17. Chemed Co. has a fifty-two week low of $492.84 and a fifty-two week high of $654.62. The stock has a market capitalization of $8.21 billion, a P/E ratio of 29.20, a P/E/G ratio of 2.20 and a beta of 0.46.

Chemed (NYSE:CHE) last released its quarterly earnings data on Wednesday, April 24th. The company reported $4.68 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $5.09 by ($0.41). Chemed had a net margin of 12.36% and a return on equity of 30.52%. The business had revenue of $589.23 million during the quarter, compared to analyst estimates of $587.18 million. Equities analysts expect that Chemed Co. will post 21.54 EPS for the current year.

Chemed Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, June 18th. Stockholders of record on Thursday, May 30th were paid a $0.40 dividend. The ex-dividend date was Thursday, May 30th. This represents a $1.60 annualized dividend and a dividend yield of 0.29%. Chemed’s payout ratio is 8.61%.

Wall Street Analysts Forecast Growth

Several analysts recently commented on the company. Royal Bank of Canada decreased their price target on Chemed from $712.00 to $697.00 and set an “outperform” rating on the stock in a research note on Tuesday, May 21st. Oppenheimer upped their price target on Chemed from $625.00 to $650.00 and gave the company an “outperform” rating in a research note on Thursday, February 29th. Finally, StockNews.com upgraded Chemed from a “hold” rating to a “buy” rating in a report on Saturday, May 4th.

Insider Activity

In related news, EVP Spencer S. Lee sold 2,000 shares of the firm’s stock in a transaction on Thursday, March 28th. The stock was sold at an average price of $641.65, for a total transaction of $1,283,300.00. Following the sale, the executive vice president now owns 20,760 shares of the company’s stock, valued at approximately $13,320,654. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. In other news, CEO Kevin J. Mcnamara sold 1,500 shares of Chemed stock in a transaction dated Thursday, June 6th. The stock was sold at an average price of $544.17, for a total value of $816,255.00. Following the completion of the transaction, the chief executive officer now directly owns 107,049 shares of the company’s stock, valued at approximately $58,252,854.33. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, EVP Spencer S. Lee sold 2,000 shares of the business’s stock in a transaction dated Thursday, March 28th. The shares were sold at an average price of $641.65, for a total value of $1,283,300.00. Following the completion of the sale, the executive vice president now directly owns 20,760 shares of the company’s stock, valued at $13,320,654. The disclosure for this sale can be found here. In the last quarter, insiders have sold 7,784 shares of company stock worth $4,523,353. Insiders own 3.32% of the company’s stock.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.